Health Condition 1: J40-J47- Chronic lower respiratory diseases
Conditions
Interventions
Intervention1: fluticasone furoate/vilanterol: fluticasone furoate 100 mcg/vilanterol 25 mcg powder for inhalation OD for 3 months.
Control Intervention1: Fluticasone furoate/salmeterol: fluticasone f
Sponsors
SRM college of pharmacy
Eligibility
Inclusion criteria
Inclusion criteria: subjects with clinical history of moderate copd in accordance with the following definition by the european respiratory society. subjects with measured FEV1/FVC ratio of 0.70 at screening. subjects with measured FEVI 70% of predicted normal values. patient willing to participate in the study and providing informed consent.
Exclusion criteria
Exclusion criteria: patients with 70 years of age and women of reproductive age (15-45 years). patients with symptoms of acute exacerbation. patients with uncontrolled diabetes mellitus and hypertension. patients on immunosuppressive drugs. patients with known trigger factors of asthma and malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| spirometry change complete blood countTimepoint: basal,14th day, 28th day,2nd month,3rd month. | — |
Secondary
| Measure | Time frame |
|---|---|
| ST.George respiratory questionnaire.Timepoint: Baseline, 3rd month. | — |
Countries
India
Contacts
Public ContactVidhya shree
SRM College of Pharmacy, SRM Institute of Science and Technology
Outcome results
None listed